The levels of IL-18 in MAS, HLH, and in children with inborn mutations, e.g., mutations in the inflammasome (NLRC4 gain of function) or XIAP (X-linked inhibition of apoptosis) deficiency mutation, are extremely high and are associated with diseases activity. This evidence concerns the gene IL18 and hemophagocytic syndrome.